Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bruchfeld

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Brain Connectivity|January 31, 2023
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19Harry Crook, Alfredo Ramirez, Akram Hosseini, et al.
Communications Medicine|December 4, 2025
Health outcomes in hospitalised and non-hospitalised individuals after COVID-19, an observational, cross-sectional studyMalin Nygren-Bonnier, Anna Svensson-Raskh, Linda Holmström, et al.
BMJ Open|June 20, 2020
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort studySimone Hj van den Elsen, Marieke Gg Sturkenboom, Onno Akkerman, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Journal of Bacteriology|November 25, 2010
African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East AfricaStefan Berg, M Carmen Garcia-Pelayo, Borna Müller, et al.
The Journal of Infection|August 11, 2018
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgerySergey E Borisov, Lia D'Ambrosio, Rosella Centis, et al.
The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The European Respiratory Journal|September 26, 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesHaileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Brain Connectivity|January 31, 2023
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19Harry Crook, Alfredo Ramirez, Akram Hosseini, et al.
Communications Medicine|December 4, 2025
Health outcomes in hospitalised and non-hospitalised individuals after COVID-19, an observational, cross-sectional studyMalin Nygren-Bonnier, Anna Svensson-Raskh, Linda Holmström, et al.
BMJ Open|June 20, 2020
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort studySimone Hj van den Elsen, Marieke Gg Sturkenboom, Onno Akkerman, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Journal of Bacteriology|November 25, 2010
African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East AfricaStefan Berg, M Carmen Garcia-Pelayo, Borna Müller, et al.
The Journal of Infection|August 11, 2018
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgerySergey E Borisov, Lia D'Ambrosio, Rosella Centis, et al.
The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The European Respiratory Journal|September 26, 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesHaileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
Pageof 10